Results of a prospective dose-intensive regimen in 27 patients with small cell carcinoma of the ovary of the hypercalcemic type

Annals of Oncology

Volumn 18, Issue 12, 2007, Pages 1985-1989

  Pautier, P ^a   Ribrag, V ^a   Duvillard, P ^a   Rey, A ^a   Elghissassi, I ^a   Sillet Bach, I ^a   Kerbrat, P ^b   Mayer, F ^c   Lesoin, A ^d   Brun, B ^e   Crouet, H ^f   Barats, J C ^a   Morice, P ^a   Lhomme C ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b CENTRE EUGÈNE MARQUIS   (France)

^c CENTRE GEORGES FRANÇOIS LECLERC   (France)

^d CENTRE OSCAR LAMBRET   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f CENTRE FRANÇOIS BACLESSE   (France)

Author keywords

Chemotherapy; High dose therapy; Ovarian cancer; Small cell carcinoma

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; ARTICLE; BLOOD TOXICITY; BONE METASTASIS; CANCER CLASSIFICATION; CANCER GROWTH; CANCER MORTALITY; CANCER RELAPSE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CYTOREDUCTIVE SURGERY; DRUG MEGADOSE; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HUMAN; HYPERCALCEMIA; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OVARY CARCINOMA; OVERALL SURVIVAL; PELVIC DISEASE; PRIORITY JOURNAL; SCHOOL CHILD; SMALL CELL CARCINOMA; STEM CELL TRANSPLANTATION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT REFUSAL; TREATMENT RESPONSE;

EID: 37349100273     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm376     Document Type: Article

References (18)

1. Dickersin GR, Kline IW, Scully RE. Small cell carcinoma of the ovary with hypercalcemia: A report of 11 cases. Cancer 1982; 49: 188-197.
2. Scully RE. Small cell carcinoma of the hypercalcemic type. Int J Gynecol Pathol 1993; 12: 148-152.
3. McCluggage WG. Ovarian neoplasms composed of small round cells: A review. Adv Anat Pathol 2004; 11: 288-296.
4. Dickersin GR, Scully RE. Ovarian small cell tumors: An electron microscopic review. Ultrastruct Pathol 1998; 22: 199-226.
5. Young RH, Oliva E, Scully RE. Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathologic analysis of 150 cases. Am J Surg Pathol 1994; 18: 1102-1116.
6. Kaplan ES, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-461.
7. Clement PB. Selected miscellaneous ovarian lesions: Small cell carcinomas, mesothelial lesions, mesenchymal and mixed neoplasms, and non-neoplastic lesions. Med Pathol 2005; 18: S113-S129.
8. Harrison ML, Hoskins P, du Bois A et al. Small cell of the ovary, hypercalcemic type - analysis of combined experience and recommendation for management. A GCIG study. Gynecol Oncol 2006; 100: 233-238.
9. Pujol JL, Daures JP, Riviére A et al. Etoposide plus cisplatin with or without the combination of 4′-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: A French Federation of Cancer Institutes multicenter phase III randomized study. J Natl Cancer Inst 2001; 93: 300-308.
10. Arriagada R, Pignon JP, Le Chevalier T. Initial chemotherapeutic doses and long-term survival in limited small-cell lung cancer. N Engl J Med 2001; 345: 1281-1282.
11. Senekjian EK, Weiser PA, Talerman A et al. Vinblastine, cisplatin, cyclophosphamide, bleomycin, doxorubicin and etoposide in the treatment of small cell carcinoma of the ovary. Cancer 1989; 64: 1183-1187.
12. Tewari K, Brewer C, Cappuccini F et al. Advanced stage small cell carcinoma of the ovary in pregnancy: Long term survival after surgical debulking and multiagent chemotherapy. Gynecol Oncol 1997; 66: 531-534.
13. Seidman JD. Small cell carcinoma of the ovary of the hypercalcemic type: p53 protein accumulation and clinicopathologic features. Gynecol Oncol 1995; 59: 283-287.
14. Bristow RE, Tomacruz RS, Armstrong DK et al. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis. J Clin Oncol 2002; 20: 1248-1259.
15. Leyvraz S, Pampallona G, Martinelli F et al. Randomized phase III study of high-dose sequential chemotherapy (CT) supported by peripheral blood progenitor cells (PBPC) for the treatment of small cell lung cancer: results of the EBMT random-ICE trial. Proc Am Soc Clin Oncol 2006; 25: 380 (Abstr 7064).
16. Powell JL, McAfee RD, McCoy RC et al. Uterine and ovarian conservation in advanced small cell carcinoma of the ovary. Obstet Gynecol 1998; 91: 846-848.
17. Sholler GL, Luks F, Mangray S et al. Advanced small cell carcinoma of the ovary in a pediatric patient with long-term survival and review of the literature. J Pediatr Hematol Oncol 2005; 27: 169-172.
18. Arriagada R, Le Chevalier T, Pignon J-P et al. Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer. N Engl J Med 1993; 329: 1848-1852.